Clinical Efficacy of Brodimoprim in the Treatment of Acute Exacerbation of Chronic Bronchitis
- 5 Downloads
Brodimoprim is a diaminopyrimidine with a broad spectrum of antimicrobial activity in vitro, which includes activity against most common lower respiratory tract pathogens. The relative clinical efficacy of this agent was assessed in a meta-analysis of 16 randomised nonblind studies in more than 450 patients with acute exacerbations of chronic bronchitis. Physician-rated global clinical efficacy with brodimoprim was greater than with amoxicillin, and equivalent to that evinced for doxycycline. There was no evidence of intergroup differences in this measure between patients receiving brodimoprim and ampicillin or cefaclor, but equivalence was unproven. Overall, global clinical efficacy tended to favour brodimoprim in comparison with all other agents. Brodimoprim was as well tolerated as comparator agents when the results of studies using the same drugs were pooled (brodimoprim vs amoxicillin, ampicillin, cefaclor or doxycycline) or results of all studies were combined (brodimoprim vs all reference drugs). However, it was not possible to prove equivalence of tolerability in any of these comparisons because of the small number of patients. Based on these results, brodimoprim is a useful alternative to standard antimicrobial agents in the treatment of patients with acute exacerbations of chronic bronchitis.
KeywordsAdis International Limited Amoxicillin Doxycycline Acute Exacerbation Chronic Bronchitis
Unable to display preview. Download preview PDF.
- 1.Reynolds HY. Chronic bronchitis and acute infectious exacerbations. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases. New York: Churchill Livingston, 1990: 531–5Google Scholar
- 2.Committee on the Aetiology of Chronic Bronchitis. Definition and classification of chronic bronchitis for clinical and epidemiological purposes: report to the Medical Research Council. Lancet 1965; 1(7389): 775–9Google Scholar
- 3.Brown RB. Managing exacerbations of chronic bronchitis. J Respir Dis 1990; 2: 353–64Google Scholar
- 5.MacFarlane JT. Acute infections of the lower respiratory tract. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine Vol. 2. Oxford: Oxford Medical Publications, 1990; 15.91–15.100Google Scholar
- 7.Rabasseda X, Mealy N. Brodimoprim: a specific dihydrofolate reductase inhibitor with high tissue penetration, long half-life and broad spectrum antibacterial activity, suitable for oral administration. Drugs Today 1994; 30: 381–99Google Scholar
- 11.Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991Google Scholar
- 13.Cohen J. Statistical power for the behavioral sciences. New York: Academic Press, 1969Google Scholar